Scientific Journal Author Lawrence A
Target the human alanine/serine/cysteine transporter 2 (ASCT2): achievement and future for novel cancer therapy
Optimize Vitamin D Levels Research has shown that vitamin D deficiency may contribute to a higher risk of blood clotting ( 12 , 13 , 14 )
Several groups have demonstrated that continuous systemic administration of rotenone to rats and mice reproduces key features of PD, including selective degeneration of the nigrostriatal dopaminergic system, activation of astroglia and microglia, formation of cytoplasmic inclusions in neurons, movement disorders, and defects in mitochondrial complex I [11, 14, 57, 62-64]
GIP receptor activation appears to amplify the metabolic benefits beyond what GLP-1 agonism alone can achieve, which is why tirzepatide consistently outperforms semaglutide in head-to-head comparisons
Long-acting formulations Exploring even longer-acting versions that might enable bi-weekly or monthly administration